Harry Jm Groen - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Clinical Lung Cancer|June 15, 2007

Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancerWouter K de Jong, Vaclav Fidler, Harry Jm Groen

EJNMMI Research|April 9, 2015

Evaluation of elastix-based propagated align algorithm for VOI- and voxel-based analysis of longitudinal (18)F-FDG PET/CT data from patients with non-small cell lung cancer (NSCLC)Gerald Sma Kerner, Alexander Fischer, Michel Jb Koole, et al.

Clinical & Translational Immunology|June 18, 2020

Immune microenvironment composition in non-small cell lung cancer and its association with survivalMenno Tamminga, Thijo Jeroen N Hiltermann, Ed Schuuring, et al.

Oncotargets and Therapy|March 14, 2019

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysisMarscha S Holleman, Harm van Tinteren, Harry Jm Groen, et al.

Oncoimmunology|July 4, 2015

Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancerPauline L de Goeje, Koen Bezemer, Marlies E Heuvers, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Clinical Lung Cancer|June 15, 2007

Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancerWouter K de Jong, Vaclav Fidler, Harry Jm Groen

EJNMMI Research|April 9, 2015

Evaluation of elastix-based propagated align algorithm for VOI- and voxel-based analysis of longitudinal (18)F-FDG PET/CT data from patients with non-small cell lung cancer (NSCLC)Gerald Sma Kerner, Alexander Fischer, Michel Jb Koole, et al.

Clinical & Translational Immunology|June 18, 2020

Immune microenvironment composition in non-small cell lung cancer and its association with survivalMenno Tamminga, Thijo Jeroen N Hiltermann, Ed Schuuring, et al.

Oncotargets and Therapy|March 14, 2019

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysisMarscha S Holleman, Harm van Tinteren, Harry Jm Groen, et al.

Oncoimmunology|July 4, 2015

Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancerPauline L de Goeje, Koen Bezemer, Marlies E Heuvers, et al.

Pageof 1